Media OutReach
World Breastfeeding Week | Gaza: Over 40% of Pregnant and Breastfeeding Women in Save The Children Clinics Malnourished
Of the 747 women Save the Children screened during the first half of July, 323 (43%) were malnourished [1] – potentially impacting their ability to care for their newborns – which was almost three times as many as in March when the Government of Israel reimposed a total siege on Gaza.
Since April, staff at Save the Children’s two primary healthcare centres operating in Gaza have reported monthly increases in the number of pregnant and breastfeeding women found to be malnourished, with food, water and fuel almost entirely unavailable. Poor nutrition and malnutrition during pregnancy can cause anaemia, pre-eclampsia, haemorrhage and death in mothers, lead to stillbirth, low birthweight, stunted growth and developmental delays for children.
Without breastfeeding support, mothers are reportedly giving their babies bottles of water or water mixed with ground chickpeas or tahini, which can increase risk of malnutrition.
Health experts globally promote breastfeeding to protect child health and improve survival, especially in the first months of life. In addition to essential nutrition, it provides antibodies that protect against common illnesses like diarrhoea, pneumonia and infections. But in Gaza, there have been reports of mothers struggling to produce breastmilk amid severe hunger, stress, dehydration and a lack of privacy caused by multiple displacements.
There are 55,000 pregnant women in Gaza, according to United Nations Population Fund [3]. More than 70,000 children under five and 17,000 pregnant or breastfeeding women are facing acute malnutrition, according to the global humanitarian authority on hunger crises, the Integrated Food Security Phase Classification (IPC) [4] which warned “the worst-case scenario of famine is currently playing out” in Gaza.
Ahmad Alhendawi, Save the Children’s Regional Director for the Middle East, North Africa and Eastern Europe, said:
“Mothers are arriving at our clinics hungry, exhausted, and terrified their babies won’t survive. Some are asking for formula so their baby can still be fed if they die. These are realities no mother should ever have to face.
“We know extreme stress can disrupt breastfeeding, and the relentless airstrikes, and obviously being in a war zone brings on a huge amount of distress – displacement and hunger in Gaza are taking a devastating toll on mothers. Many women are malnourished themselves yet still trying to nourish their babies. Supporting mothers to breastfeed can be a life-saving intervention for both mother and child.”
“When babies have no food, their bodies will start to shut down after a few days. They stop eating, lose energy, and start to waste away. Eventually their organs begin to fail and they become dangerously vulnerable to infection. Malnutrition is treatable and children can recover, but only if we reach them in time. The siege on entry of aid into Gaza must be urgently lifted. With sufficient, safe, and predictable entry processes and routes, humanitarian organisations know how to get the right assistance to people in time to save lives. Anything else, anything less, is a dangerous distraction that is costing mothers their babies, babies their mothers and, in the “best case” scenario, undermining children’s growth, development, and futures. If the world does not act now, more children will die from this preventable, man-made crisis.”
Kalina Tsang, CEO of Save the Children Hong Kong, added:
“It is a mother’s worst nightmare to be unable to feed her own child. The reports from our clinics in Gaza, of mothers so malnourished they cannot breastfeed and so desperate they are preparing for their own deaths, are utterly devastating. This is a complete collapse of humanity. We cannot turn away. I urge the public to help us reach these mothers and babies before it is too late. Your contribution to our Children’s Emergency Fund can provide critical nutritional support and save lives, whenever humanitarian channels are available, in this man-made catastrophe.”
The Gaza Ministry of Health has reported that 180 people have died of malnutrition-related causes since the start of the war in October 2023, including 93 children with at least 25 of these children dying in July as malnutrition rises on a dangerous trajectory.
Save the Children is calling on the Government of Israel to uphold their obligations under international law and allow total access for all aid including breastfeeding support and, in the case of those who have no other option, the entry of infant formula and the essential supplies and services required for their regulated, targeted use in a way that is as hygienic as possible. Infants already devastated by war must not be left without the means to survive. Infant formula and the supplies required to administer it in a hygienic way, like all aid, has been restricted from entering Gaza due to the Israeli government-imposed siege on supplies.
Save the Children has been working in Gaza for decades, running primary healthcare centres and providing essential services to children, mothers, and families, including screening and treatment for malnutrition. We are ready to scale-up lifesaving aid alongside our partners. Our teams deliver water, run child-friendly spaces and mother and baby areas where pregnant and breastfeeding women can receive support on nutrition and infant feeding and psychosocial care. We also set up temporary learning centres to help children continue their education.
NOTE TO EDITORS:
World Breastfeeding Week is held in the first week of August every year, highlighting that breastfeeding is one of the most effective ways to ensure child health and survival.
[1]Save the Children screened 747 women from July 1st to 17th 323 (43%) of which were malnourished.
[4]https://www.ipcinfo.org/fileadmin/user_upload/ipcinfo/docs/IPC_GazaStrip_Alert_July2025.pdf
Hashtag: #SavetheChildren #Gaza #breastfeeding #WorldBreastfeedingWeek #Malnutrition #starvation #hunger
https://savethechildren.org.hk/en/
https://www.linkedin.com/company/save-the-children-hong-kong
https://www.facebook.com/savethechildrenhk
https://www.instagram.com/savethechildrenhk/
https://www.youtube.com/user/savehk
The issuer is solely responsible for the content of this announcement.
Save the Children Hong Kong
Save the Children believes every child deserves a future. In Hong Kong and around the world, we do whatever it takes – every day and in times of crisis – so children can fulfil their rights to a healthy start in life, the opportunity to learn and protection from harm. With over 100 years of expertise, we are the world’s first and leading independent children’s organisation – transforming lives and the future we share.
Established in 2009, Save the Children Hong Kong is part of the global movement which operates in around 100 countries. We work with children, families, schools, communities and our supporters to deliver lasting change for children in Hong Kong and around the world.
Visit our website, or follow us on Facebook, Instagram, LinkedIn, and YouTube.
Media OutReach
Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in three additional markets in Asia
Following the acquisition, Zuellig Pharma will now own the trademarks, marketing authorizations and license manufacturing know-how for Cialis®, a treatment for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), in 11 markets in Asia, with the expansion of its ownership into three additional markets beyond the original eight. Zuellig Pharma will also continue to promote and distribute the brand in these markets.
The expanded ownership of Cialis® will widen accessibility of the drug to a significant population of men in Asia who are affected by ED and BPH. The acquisition also aligns with Zuellig Pharma’s strategic priority of building a strong portfolio of owned prescription healthcare products as an integrated healthcare solutions company.
“Our acquisition of Cialis® in three additional markets builds on the strong foundation we established two years ago and highlights our proven success in scaling trusted brands effectively through our commercial capabilities and deep expertise. As we broaden our footprint, we remain focused on delivering sustainable growth and advancing our purpose of making in-demand healthcare solutions more accessible to communities in Asia,” said John Graham, CEO of Zuellig Pharma.
Hashtag: #ZuelligPharma #EliLillyandCompany #Cialis #MensHealth #Healthcare #Pharmaceuticals
https://www.zuelligpharma.com/
https://www.linkedin.com/company/zuellig-pharma
The issuer is solely responsible for the content of this announcement.
About Zuellig Pharma
Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to the communities we serve. We provide world-class distribution, commercialization, and clinical trial support services, underpinned by a strong culture of innovation to support the growing healthcare needs in this region. The company was founded a hundred years ago and has grown to become a multibillion-dollar business covering 18 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.
Media OutReach
Ingdan Powers Embodied AI with Humanoid-Style Brain-Cerebellum Chipset to Boost Robotics Ecosystem
2026 is widely regarded as a milestone year for humanoid robotics, in which humanoid robots transition from laboratory prototypes and demonstration performances to large‑scale mass production. At CES in January, NVIDIA announced the commercial launch of its physical‑AI core platform Jetson Thor. Tesla is scheduled to officially release the mass‑production engineering version of its Optimus (V3) humanoid robot by the end of March, with plans to initiate million‑unit‑level production lines by the end of 2026—an inflection point widely regarded as the “Model 3 moment” of the humanoid robotics industry. At the same time, Chinese robotics companies such as AGIBOT, Unitree, and Fourier Intelligence have already deployed products at scale in warehousing and logistics scenarios.
Against this backdrop, the upstream hardware focus of the humanoid robotics industry is increasingly converging on “Brain-Cerebellum” collaboration and low‑latency, multi‑joint real‑time control, which are essential to achieving coordinated, smooth, and human‑like robotic motion. During the CMG Spring Festival Gala, robots from multiple companies demonstrated complex coordinated movements and dexterous hand operations, further highlighting the value of this technical direction.
D‑Robotics, originating from the AIoT and robotics division of Horizon Robotics, focuses on edge‑side embodied intelligence solutions characterized by high computing power, integrated computation and control, and low latency. Leveraging its parent company’s long‑term experience in intelligent driving, D‑Robotics has established a precise position in humanoid robot “Brain-Cerebellum” coordination and real‑time joint control.
In November 2025, D‑Robotics unveiled its flagship robotics computing platform S600, with an official release planned for the end of the first quarter of 2026. The S600 platform features a highly integrated humanoid‑style “Brain-Cerebellum” chipset architecture. Its “Brain” configuration combines an 18‑core A78AE CPU with a proprietary Nash‑architecture BPU, delivering 560 TOPS (INT8) edge computing power and supporting efficient deployment of VLA, VLM, LLM, and locomotion models. Its “Cerebellum” configuration integrates a 6‑core R52+ MCU, providing high‑reliability, real‑time motion control.
By integrating CPU, BPU, and real‑time MCU capabilities into a single SoC, S600 enables a closed‑loop architecture encompassing perception, decision‑making, and real‑time action control. This design addresses a key industry challenge in which many edge AI processors lack embedded real‑time MCUs and rely on external controllers, resulting in excessive latency. The integrated MCU supports high‑frequency, high‑precision PWM signal generation based on FOC algorithms, enabling precise motor control and contributing to stable rhythm and natural gait.
The S600 platform has been adopted by multiple robotics companies such as Fourier Intelligence, Booster Robotics, X Square Robot, and ROBOTERA, supporting applications that require stable multi‑joint coordination and smooth motion performance.
Ingdan, Inc. (00400.HK) is a core supplier in the AI computing power supply chain and an application technology solutions provider covering both AI infrastructure and AI intelligent terminals. The Company represents a broad portfolio of international semiconductor manufacturers, including NVIDIA, Xilinx, Intel, AMD, and SanDisk, as well as numerous domestic chip vendors. It serves hundreds of robotics manufacturers and Tier‑1 customers and has formed a comprehensive embodied intelligence ecosystem.
D‑Robotics is a core product line Ingdan distributes . Building on D‑Robotics’ products and combined with its own technical services—such as multi‑sensor fusion development, real‑time closed‑loop tuning, Quantization‑Aware Training (QAT) support, simulation testing, and modular SOM customization—the Group has supported sophisticated customers including Galbot and ROBOTERA, continuously enriching the robotics industry ecosystem.
Looking ahead, Ingdan will continue to focus on the humanoid robotics sector. Leveraging an IC product matrix centered on NVIDIA Jetson and D‑Robotics platforms, the Company aims to further strengthen its AI intelligent terminal capabilities and continue supporting the iterative development of embodied intelligence products.
For investor and media enquiries
Please email to **@****an.com
Hashtag: #Ingdan #Chips #humanoid #D‑Robotics #NVIDIA #Tech
The issuer is solely responsible for the content of this announcement.
Ingdan, Inc.
Ingdan, Inc. (00400.HK) is a core supplier in the AI computing power supply chain and an application technology solutions provider covering both AI infrastructure and AI intelligent terminals. The Company represents a broad portfolio of international semiconductor manufacturers, including NVIDIA, Xilinx, Intel, AMD, and SanDisk, as well as numerous domestic chip vendors. It serves hundreds of robotics manufacturers and Tier‑1 customers and has formed a comprehensive embodied intelligence ecosystem.
Media OutReach
Snow, Ice, and Performance: 2026 Changan Global Testing Season Arrives in Europe with Back-to-Back Winter Events
- European dealers and journalists experienced the CHANGAN DEEPAL S05 AWD at 2026 Changan Global Testing Season this February.
- With intelligent AWD and advanced ADAS, the CHANGAN DEEPAL S05 AWD offered uncompromising safety and control on winter roads.
Saalfelden, Austria – Media OutReach Newswire – 12 March 2026 – Following extreme cold tests in Yakeshi, China, the 2026 Changan Global Testing Season made its European debut this February with the Changan Winter Experience in Courmayeur and the Winter Test Drives in Saalfelden. The all-electric CHANGAN DEEPAL S05 AWD was tested on snow and ice—familiar conditions for European drivers—offering dealers and journalists an immersive introduction to Changan’s electric mobility vision through dynamic drives.
Three-time Olympic gold medalist and Milano Cortina 2026 Ambassador Deborah Compagnoni joined the event in Courmayeur, testing the CHANGAN DEEPAL S05 AWD. Her career—defined by determination, control, and reliability—reflects Changan’s core values. “I felt that the principles of trajectory and speed in skiing apply to driving. With this model, you gain confidence on challenging terrain,” she said.
Snow-Validated Performance: The CHANGAN DEEPAL S05 AWD
Tested in Europe, the CHANGAN DEEPAL S05 AWD demonstrated controllable dynamics, reliable traction, and enhanced safety—highlighting its cutting-edge AWD and ADAS. The system adapts seamlessly: ECO/COMFORT modes prioritize RWD efficiency, while AWD will engage automatically when sensors detect slip, high torque demand, or extreme cold below -25°C. SPORT mode delivers permanent 50:50 torque for sharper response. SNOW mode maintains balanced torque with optimized slip control for confident driving on low-grip surfaces.
The intelligent AWD system delivers up to 320 kW power, 502 Nm torque, and 0–100 km/h acceleration in 5.5 seconds. It also improves hill climbing with a 40% gradient capability, ensures stability by actively balancing power to prevent skidding, and enables safer cornering at higher speeds through optimized grip and vehicle dynamics.
Changan Standard: Proven in the Alps, Bound for the World
Changan Standard is defined by a principle: forged in extremes, built for every day. From Yakeshi to the Alps, the test environments are selected to verify specific performance attributes—safety technologies, chassis response, all-wheel-drive calibration, and ADAS in low-grip scenarios. The objective of 2026 Global Testing Season is not to demonstrate extremes, but to confirm consistency: that the same level of safety, control, and stability demonstrated will be replicated in Mexico, Thailand, and Saudi Arabia.
Hashtag: #Changan
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn